AIM-HI is a new paradigm to fund translational research designed to focus on startups that have commercial potential at the early stage of cancer therapeutic discovery.

Read Our Story
AIM-HI Accelerator Program Image

Accelerator Program

Most venture capital funds claim to engage in “active management,” while in fact, doing little more than assuming passive board roles.  AIM-HI will be actively involved in all portfolio companies…

Venture Competition

At the end of the competition, there will be two awardees – winner and runner-up. The awardees will receive up to $25,000 from AIM-HI as cash prize and being accepted into the Accelerator program…

Impact Investment

We estimate that the U.S. spends about USD 20 billion a year on cancer research, but only 0.5 percent of that goes toward translating research out of the lab and into the real world, where it can change and save lives.

Our Mission

AIM-HI’s mission is to accelerate the cancer drug discovery process and make it sustainable with the pharmaceutical industry for further development and then re-invest into the bench research process, for perpetuity.

Featured Startups

OncoHeroes Biosciences Logo
Startup ILCT Logo
InVaMet Therapeutics Logo
Stromatis Pharma Startup Logo
Rasio Therapeutics

AIM-HI Women Bioentrepreneurs Venture Competition - win up to $100,000 in seed funding!

Learn More
AIM-HI Homepage Laboratory Image

Learn More About Us

Register to learn how charitable giving can help cancer startups cross the Valley of Death.

Sign Up for Newsletters
Back To Top